Overview

Orum Therapeutics, Inc. is a biopharmaceutical company leveraging our proprietary platforms for research and development of new pharmaceuticals for cancer and immune diseases. We are pioneering a class of therapeutics intended to expand the universe of druggable targets and to meaningfully improve upon potency and tolerability, and thereby improve the therapeutic window of drugs.

Our goal is to bring life-changing therapies to patients by combining the power of the emerging field of protein degraders with the precision of antibodies to generate a broad portfolio of highly differentiated product candidates.

Our Leaders

Susan Best H. HR

Olaf Christensen CMO

Greg Dwyer H. BD

Martin Intae Jeong CFO

SJ Lee CEO

Chris Martin H. Legal

Advisory Board

Billy Cho
Senior Managing Director of CBC Group

Maria Koehler
CMO, Repare Therapeutics

Geoff Meyerson
CEO & Co-founder, Locust Walk

Peter U Park
CEO, Tesseract Medicines

Board of Directors

SJ Lee
CEO, Orum Therapeutics

Peter U Park
Scientific Committee Chair
CEO, Tesseract Medicines

Jinwoo Jo
CEO, Beyond Music

Martin Jeong
CFO, Orum Therapeutics

Meet the Team